Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Phone214-937-2000
Debt
Current Ratio3.19
Quick Ratio2.15
Price-To-Earnings
Sales & Book Value
Annual Sales$433.82 million
Price / Sales2.22
Price / Cash FlowN/A
Price / BookN/A
Profitability
Net Income$6.22 million
Net Margins1.45%
Return on Assets8.05%
Miscellaneous
Employees858
OptionableOptionable
Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions
What is Orthofix Medical's stock symbol?
Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."
How were Orthofix Medical's earnings last quarter?
Orthofix Medical Inc (NASDAQ:OFIX) released its earnings results on Monday, October, 29th. The medical device company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.34 by $0.09. The medical device company earned $111.70 million during the quarter, compared to analysts' expectations of $110.65 million. Orthofix Medical had a return on equity of 10.97% and a net margin of 1.45%. The firm's revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the firm posted $0.42 earnings per share. View Orthofix Medical's Earnings History.
When is Orthofix Medical's next earnings date?
What guidance has Orthofix Medical issued on next quarter's earnings?
Orthofix Medical issued an update on its FY18 earnings guidance on Monday, October, 29th. The company provided EPS guidance of $1.70-1.75 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.68. Orthofix Medical also updated its FY 2018 guidance to $1.70-1.75 EPS.
What price target have analysts set for OFIX?
3 equities research analysts have issued 12-month price objectives for Orthofix Medical's stock. Their forecasts range from $66.00 to $67.00. On average, they anticipate Orthofix Medical's stock price to reach $66.50 in the next year. This suggests a possible upside of 30.6% from the stock's current price. View Analyst Price Targets for Orthofix Medical.
What is the consensus analysts' recommendation for Orthofix Medical?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthofix Medical.
Has Orthofix Medical been receiving favorable news coverage?
Media headlines about OFIX stock have been trending positive on Thursday, InfoTrie reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Orthofix Medical earned a media sentiment score of 2.3 on InfoTrie's scale. They also gave news stories about the medical device company a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an impact on the stock's share price in the next several days.
Who are some of Orthofix Medical's key competitors?
Some companies that are related to Orthofix Medical include Cantel Medical (CMD), Merit Medical Systems (MMSI), Tandem Diabetes Care (TNDM), NuVasive (NUVA), Glaukos (GKOS), Irhythm Technologies (IRTC), Mazor Robotics (MZOR), Atrion (ATRI), K2M Group (KTWO), Nevro (NVRO), AtriCure (ATRC), Tactile Systems Technology (TCMD), Luminex (LMNX), Cryolife (CRY) and Cardiovascular Systems (CSII).
Who are Orthofix Medical's key executives?
Orthofix Medical's management team includes the folowing people:
- Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)
- Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)
- Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)
- Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)
- Mr. Davide Bianchi, Pres of Global Orthofix Extremities (Age 54)
Who are Orthofix Medical's major shareholders?
Orthofix Medical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Louisiana State Employees Retirement System (0.04%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick, Raymond Fujikawa, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical.
Which institutional investors are selling Orthofix Medical stock?
OFIX stock was sold by a variety of institutional investors in the last quarter, including Louisiana State Employees Retirement System. Company insiders that have sold Orthofix Medical company stock in the last year include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick and Rice Doug. View Insider Buying and Selling for Orthofix Medical.
How do I buy shares of Orthofix Medical?
Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Orthofix Medical's stock price today?
One share of OFIX stock can currently be purchased for approximately $50.93.
How big of a company is Orthofix Medical?
Orthofix Medical has a market capitalization of $927.46 million and generates $433.82 million in revenue each year. The medical device company earns $6.22 million in net income (profit) each year or $1.62 on an earnings per share basis. Orthofix Medical employs 858 workers across the globe.
What is Orthofix Medical's official website?
How can I contact Orthofix Medical?
Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]
MarketBeat Community Rating for Orthofix Medical (NASDAQ OFIX)
MarketBeat's community ratings are surveys of what our community members think about Orthofix Medical and other stocks. Vote "Outperform" if you believe OFIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
